Read the segment table, not the company total. Northrop Grumman's 2021 Form 10-K breaks backlog out by business, and the Aeronautics Systems line shows total backlog falling roughly 24% during 2021 — from $24,002 million to $18,277 million. A consolidated backlog figure can stay healthy while one segment's runway shortens, which is exactly the kind of divergence the segment disclosure exists to surface. Northrop's company-wide total backlog ended 2021 at $76,046 million, down a much milder 6% from $80,969 million; the Aeronautics decline was four times steeper than the consolidated number alone would suggest.

The composition of that segment number matters as much as the headline. The 10-K's backlog table splits Aeronautics into $8,842 million funded and $9,435 million unfunded, for the $18,277 million total. Funded backlog is the portion already covered by appropriations and obligated dollars; unfunded backlog reflects exercised but not-yet-funded options and indefinite-quantity orders. With more than half of Aeronautics backlog sitting in the unfunded column, the runway's conversion to recognized sales is more dependent on future appropriations than a single total implies — another reason the segment line carries more information than the company total.

The decline also lines up with the segment's 2021 operating results, which is what makes it a forward signal rather than noise. The 10-K reports Aeronautics Systems sales of $11,259 million in 2021, down $910 million, or 7%, from $12,169 million in 2020, with operating income of $1,093 million (down 9%) and the operating margin rate easing to 9.7% from 9.9%. The filing attributes the sales decline to "lower volume in both Manned Aircraft and Autonomous Systems," specifically a $444 million sale of equipment to a restricted customer that landed in 2020, $150 million of lower F-35 sales, lower A350 production activity, and reduced volume on the B-2 Defensive Management Systems Modernization and certain Global Hawk programs. A backlog that fell faster than sales is a runway shortening ahead of the revenue line — the classic case for reading book-to-bill at the segment, not company, level.

For a markets desk, a 24% segment-backlog decline is a forward-revenue flag worth understanding before it shows up in sales. Aeronautics backlog can fall for benign reasons — a large prior-year award being worked off, timing between program phases — or for structural ones, such as a program maturing without a replacement. The filing's job is to disclose the number; the analyst's job is to read which kind of decline it is. Northrop's own award detail offers some reassurance: 2021 net awards totaled $32.1 billion company-wide, including $2.2 billion for F-35 and a share of $6.1 billion in restricted-program awards that touched Aeronautics, suggesting the segment was still booking work even as its backlog net-declined.

The cross-segment table sharpens the contrast. Northrop's 2021 segment sales were Aeronautics Systems $11,259 million, Mission Systems $10,092 million (organic, up 6%), Space Systems $10,592 million (up 24%), and Defense Systems $5,670 million. Total company sales were $35,505 million, up 3%. So in a year when the consolidated top line grew and Space was compounding at 24% on SLS and Next Generation Interceptor work, Aeronautics was simultaneously shrinking on both sales and backlog. An investor anchored on the company's growing total would have entirely missed that one of four core segments was in retreat — the single clearest argument for reading the segment disclosures the 10-K is required to provide.

The structural context is that Northrop runs four distinct segments — Aeronautics, Defense, Mission and Space — each on its own program clock. Space Systems told the opposite story in the same table, with sales up 24% on the SLS and NGI franchises, so a strong space book partly offset a softening aeronautics book at the company level. That is precisely why backlog should be read by segment: the consolidated 6% decline blends a sharply contracting Aeronautics runway with growth elsewhere, and an investor watching only the total would miss both moves. The filing also notes a $1.4 billion backlog reduction tied to the IT services divestiture in the first quarter of 2021, a reminder that portfolio actions, not just program performance, move these numbers.

What separates a worrying backlog decline from a benign one is whether the work that rolled off has a replacement queued. Northrop's award detail gives a mixed read for Aeronautics: the segment shared in $6.1 billion of restricted-program awards and booked $2.2 billion of F-35 orders, but the $444 million restricted-customer equipment sale that inflated 2020 had no obvious 2021 analog, and F-35 sales fell year over year. That is the profile of a segment digesting a high prior-year base rather than collapsing — but with backlog down 24% and more than half of it unfunded, the margin for error narrowed. The disclosure does the reporting; the trajectory is what the next year's awards will decide.

The forward question entering 2022 is whether new Aeronautics awards refill the runway or whether the decline persists into recognized sales. With the unfunded share elevated and sales already down 7%, the segment needed fresh funded awards to stabilize its trajectory rather than simply ride existing options. Track segment book-to-bill, the funded-versus-unfunded split, and whether F-35 and B-2 modernization volumes find a floor — not just the consolidated total. For a markets reader, the lesson generalizes beyond Northrop: at any multi-segment prime, the consolidated backlog is an average that can hide a segment turning down a year before its revenue does, and the segment table is the only place that divergence is visible early. Filing on sec.gov; index via SEC filings.